compounded glp-1 ban New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our The Crackdown on Compounded GLP-1

Lifestyle changes, influence of social media, celebrity endorsements and direct to consumer advertisements have led to a surge in the demand for GLP-1 drugs

Similarly, modification of Gram-negative bacterias lipopolysaccharides (LPS) is another bacterial mechanism contributing to resistance (Gunn, 2001

Biochem Biophys Res Commun 492:243248

Many hormones such as GCs or insulin can use more than one type of action, which allows for an even more fine-tuned circadian response

PlexusDx takes precision wellness further by examining how genetic variants in your GLP-1 receptor pathway may influence treatment response, allowing for more personalized therapy planning with your healthcare provider